While non-headache, non-oral craniofacial neuralgia is relatively rare in incidence and prevalence, it can result in debilitating pain. Understanding the relevant anatomy of peripheral branches of nerves, natural history, clinical presentation, and management strategies will help the clinician better diagnose and treat craniofacial neuralgias. This article will review the nerves responsible for neuropathic pain in periorbital, periauricular, and occipital regions, distinct from idiopathic trigeminal neuralgia. The infratrochlear, supratrochlear, supraorbital, lacrimal, and infraorbital nerves mediate periorbital neuralgia. Periauricular neuralgia may involve the auriculotemporal nerve, the great auricular nerve, and the nervus intermedius. The greater occipital nerve, lesser occipital nerve, and third occipital nerve transmit occipital neuralgias. A wide range of treatment options exist, from modalities to surgery, and the evidence behind each is reviewed.
Agrawal,S. M., & Kambalimath,D. H. (2010). Trigeminal neuralgia involving supraorbital and infraorbital nerves. National Journal of Maxillofacial Surgery, 1(2), 179–182. https://doi.org/10.4103/0975-5950.79226.
2.
Ahmed,S. U., Zhang,Y., Chen,L., Cohen,A., St Hillary,K., Vo,T., Houghton,M., & Mao,J. (2015). Effect of 1.5% Topical Diclofenac on Clinical Neuropathic Pain. Anesthesiology, 123(1), 191–198. https://doi.org/10.1097/ALN.0000000000000693.
3.
Alcántara Montero,A., & Sánchez Carnerero,C. I. (2019). Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience. Acetato de eslicarbazepina en dolor neuropático, cefaleas y neuralgias craneales: Evidencia y experiencia. Neurologia (Barcelona, Spain), 34(6), 386–395. https://doi.org/10.1016/j.nrl.2016.11.009.
4.
Anitescu,M., Benzon,H. T., & Argoff,C. E. (2013). Advances in topical analgesics. Current Opinion in Anaesthesiology, 26(5), 555–561. https://doi.org/10.1097/01.aco.0000432514.00446.22.
5.
Antony,A. B., Mazzola,A. J., Dhaliwal,G. S., & Hunter,C. W. (2019). Neurostimulation for the Treatment of Chronic Head and Facial Pain: A Literature Review. Pain Physician, 22(5), 447–477.
6.
Barmherzig,R., & Kingston,W. (2019). Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management. Current Neurology and Neuroscience Reports, 19(5), 20.https://doi.org/10.1007/s11910-019-0937-8.
7.
Barral,J., & Croibier,A. (2009). Evaluation and treatment of cranial nerves. In J. Barral and A. Croibier. (Eds.) Manual Therapy for the Cranial Nerves, London: Churchill Livingstone. https://doi.org/10.1016/B978-0-7020-3100-7.50011-2.
8.
Barros,G. A., Miot,H. A., Braz,A. M., Ramos,F., & Borges,M. A. (2012). Topical (S)-ketamine for pain management of postherpetic neuralgia. Anais Brasileiros de Dermatologia, 87(3), 504–505. https://doi.org/10.1590/s0365-05962012000300032.
9.
Beigi,B., Beigi,M., Niyadurupola,N., Saldana,M., El-Hindy,N., & Gupta,D. (2017). Infraorbital Nerve Decompression for Infraorbital Neuralgia/Causalgia following Blowout Orbital Fractures: A Case Series. Craniomaxillofacial Trauma & Reconstruction, 10(1), 22–28. https://doi.org/10.1055/s-0036-1592095.
10.
Belvís,R., & Guerrero,Á. L. (2019). Benito’s neuralgia: the first description of the occipital neuralgia was made for Spanish doctors at the beginning of the nineteenth century. Neurological sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 40(11), 2425–2429. https://doi.org/10.1007/s10072-019-03734-5.
11.
Bendtsen,L., Birk,S., Kasch,H., Aegidius,K., Sørensen,P. S., Thomsen,L. L., Poulsen,L., Rasmussen,M. J., Kruuse,C., Jensen,R., Danish Headache Society (2012). Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. The journal of headache and pain, 13 Suppl 1: S1-S29. https://doi.org/10.1007/s10194-011-0402-9.
Besi,E., Boniface,D. R., Cregg,R., & Zakrzewska,J. M. (2015). Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP. The Journal of Headache and Pain, 16, 563. https://doi.org/10.1186/s10194-015-0563-z.
14.
Blumenfeld,A., Ashkenazi,A., Napchan,U., Bender,S. D., Klein,B. C., Berliner,R., Ailani,J., Schim,J., Friedman,D. I., Charleston,L.4th, , Young,W. B., Robertson,C. E., Dodick,D. W., Silberstein,S. D., & Robbins,M. S. (2013). Expert consensus recommendations for the performance of peripheral nerve blocks for headaches–a narrative review. Headache, 53(3), 437–446. https://doi.org/10.1111/head.12053.
15.
Blumenfeld,A., & Nikolskaya,G. (2013). Glossopharyngeal neuralgia. Current Pain and Headache Reports, 17(7), 343.
16.
Bogduk,N. (1982). Clinical Anatomy of the Cervical Dorsal Rami. Spine, 7, 319–330.
17.
Bovim,G., Fredriksen,T. A., Stolt-Nielsen,A., & Sjaastad,O. (1992). Neurolysis of the greater occipital nerve in cervicogenic headache. A follow up study. Headache, 32(4), 175–179. https://doi.org/10.1111/j.1526-4610.1992.hed3204175.x.
18.
Campbell,R. L., Parks,K. W., & Dodds,R. N. (1990). Chronic facial pain associated with endodontic therapy. Oral Surg Oral Med Oral Pathol, 69, 287–290.
19.
Candido,K. D., Massey,S. T., Sauer,R., Darabad,R. R., & Knezevic,N. N. (2013). A novel revision to the classical transnasal topical sphenopalatine ganglion block for the treatment of headache and facial pain. Pain Physician, 16(6), E769–E778.
20.
Cesmebasi,A., Muhleman,M. A., Hulsberg,P., Gielecki,J., Matusz,P., Tubbs,R. S., & Loukas,M. (2015). Occipital neuralgia: anatomic considerations. Clinical anatomy (New York, N.Y.), 28(1), 101–108. https://doi.org/10.1002/ca.22468.
21.
Chavarría-Miranda,A., Guerrero,A. L., & García-Azorín,D. (2018). Sequential Presentation of Ipsilateral Supraorbital and Lacrimal Neuralgias in a Patient. Pain Medicine (Malden, Mass.), 19(12), 2577–2579. https://doi.org/10.1093/pm/pny103.
Choi,I., & Jeon,S. R. (2016). Neuralgias of the head: Occipital neuralgia. J Korean Med Sci, 31, 479–488.
24.
Chole,R., Patil,R., Degwekar,S. S., & Bhowate,R. R. (2007). Drug treatment of trigeminal neuralgia: a systematic review of the literature. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons, 65(1), 40–45. https://doi.org/10.1016/j.joms.2005.12.063.
25.
Chou,D. E., Shnayderman Yugrakh,M., Winegarner,D., Rowe,V., Kuruvilla,D., & Schoenen,J. (2019). Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia: an International Journal of Headache, 39(1), 3–14. https://doi.org/10.1177/0333102418811573.
26.
Costa,B., Giagnoni,G., Franke,C., Trovato,A. E., & Colleoni,M. (2004). Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. British Journal of Pharmacology, 143(2), 247–250. https://doi.org/10.1038/sj.bjp.0705920.
27.
Cramer,G. D. The Cervical Spine In Cramer GD, Darby SA (Eds). (2014). Clinical Anatomy of the Spine, Spinal Cord, and ANS (Third Edition). Lombard, IL: Mosby.
28.
Cruccu,G., Gronseth,G., Alksne,J., Argoff,C., Brainin,M., Burchiel,K., Nurmikko,T., Zakrzewska,J. M., American Academy of Neurology Society, European Federation of Neurological Society (2008). AAN-EFNS guidelines on trigeminal neuralgia management. European Journal of Neurology, 15(10), 1013–1028. https://doi.org/10.1111/j.1468-1331.2008.02185.x.
29.
Cuadrado,M. L., Aledo-Serrano,Á., & Ruiz-Álvarez,L. (2015). Eslicarbazepine acetate for a patient with highly resistant epicrania fugax. Pain Practice: the Official Journal of World Institute of Pain, 15(1), E27. https://doi.org/10.1111/papr.12261.
30.
Cuadrado,M. L., Gutiérrez-Viedma,Á., Silva-Hernández,L., Orviz,A., & García-Moreno,H. (2017). Lacrimal Nerve Blocks for Three New Cases of Lacrimal Neuralgia. Headache, 57(3), 460–466. https://doi.org/10.1111/head.12985.
31.
Cytowic,R. E. (1990). Nerve block for common pain. New York: Springer-Verlag
De Benedittis,G., Besana,F., & Lorenzetti,A. (1992). A new topical treatment for acute herpetic neuralgia and post-herpetic neuralgia: the aspirin/diethyl ether mixture. An open-label study plus a double-blind controlled clinical trial. Pain, 48(3), 383–390. https://doi.org/10.1016/0304-3959(92)90088-s.
34.
Deer,T. R., Mekhail,N., Petersen,E., Krames,E., Staats,P., Pope,J., Saweris,Y., Lad,S. P., Diwan,S., Falowski,S., Feler,C., Slavin,K., Narouze,S., Merabet,L., Buvanendran,A., Fregni,F., Wellington,J., Levy,R. M., Neuromodulation Appropriateness Consensus Committee (2014). The appropriate use of neurostimulation: stimulation of the intracranial and extracranial space and head for chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation: journal of the International Neuromodulation Society, 17(6), 551–570. https://doi.org/10.1111/ner.12215.
35.
De Toledo,I. P., Conti Réus,J., Fernandes,M., Porporatti,A. L., Peres,M. A., Takaschima,A., Linhares,M. N., Guerra,E., & De Luca Canto,G. (2016). Prevalence of trigeminal neuralgia: A systematic review. Journal of the American Dental Association (1939), 147(7), 570–576.e2. https://doi.org/10.1016/j.adaj.2016.02.014.
36.
Devor,M., Amir,R., & Rappaport,Z. H. (2002). Pathophysiology of Trigeminal Neuralgia: The Ignition Hypothesis. The Clinical Journal of Pain, 18(1), 4–13.
37.
Di Stefano,G., Truini,A., & Cruccu,G. (2018). Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. Drugs, 78(14), 1433–1442. https://doi.org/10.1007/s40265-018-0964-9.
38.
Duvall,J. R., Garza,I., Kissoon,N. R., & Robertson,C. E. (2020). Great Auricular Neuralgia: Case Series. Headache, 60(1), 247–258. https://doi.org/10.1111/head.13690.
39.
Eghtesadi,M., Leroux,E., & Vargas-Schaffer,G. (2017). A case report of complex auricular neuralgia treated with the great auricular nerve and facet blocks. Journal of pain research, 10, 435–438. https://doi.org/10.2147/JPR.S126923.
40.
Elahi,F., & Reddy,C. G. (2015). Sphenopalatine ganglion electrical nerve stimulation implant for intractable facial pain. Pain Physician, 18(3), E403–E409.
41.
Feller,L., Khammissa,R., Fourie,J., Bouckaert,M., & Lemmer,J. (2017). Postherpetic Neuralgia and Trigeminal Neuralgia. Pain Research and Treatment, 2017, 1681765. https://doi.org/10.1155/2017/1681765.
42.
Finnerup,N. B., Attal,N., Haroutounian,S., McNicol,E., Baron,R., Dworkin,R. H., Gilron,I., Haanpää,M., Hansson,P., Jensen,T. S., Kamerman,P. R., Lund,K., Moore,A., Raja,S. N., Rice,A. S., Rowbotham,M., Sena,E., Siddall,P., Smith,B. H., & Wallace,M. (2015). Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology, 14(2), 162–173. https://doi.org/10.1016/S1474-4422(14)70251-0.
43.
Gambeta,E., Chichorro,JG., & Zamponi,GW. (2020). Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. Mol Pain, 2020;16:1744806920901890. doi:10.1177/1744806920901890
44.
Garcia,J. B., Ferro,L. S., Carvalho,A. B., da Rocha,R. M., & de Souza,L. M. (2010). Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report. Revista Brasileira de Anestesiologia, 60(4), 429–437. https://doi.org/10.1016/S0034-7094(10)70053-2.
45.
George,D. D., & Ridder,T. S. (2020). Geniculate neuralgia in an adolescent treated via sectioning of the nervus intermedius and microvascular decompression. Journal of Neurosurgery Pediatrics, 1-4. Advance online publication.
46.
Gonzalez-Garcia,R., Rodriguez-Campo,F. J., Escorial-Hernandez,V., Munoz-Guerra,M. F., & Sastre-Perez,J. L. (2006). Complications of temporomandibular joint arthroscopy: a retrospective analytic study of 670 arthroscopic procedures. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons, 64(11), 1587–1591. https://doi.org/10.1016/j.jos.2005.12.058.
Hammond,F. M., Katta-Charles,S. D., Cranial Nerves In Zasler,N. D., Katz,D. I., Zafonte,R. D. (Eds.). (2021). Brain injury medicine: Principles and practice. NY, NY: Demos Medical Publishing. Manuscript submitted for publication
49.
Haviv,Y., Zadik,Y., Sharav,Y., & Benoliel,R. (2014). Painful traumatic trigeminal neuropathy: an open study on the pharmacotherapeutic response to stepped treatment. Journal of Oral & Facial Pain and Headache, 28(1), 52–60. https://doi.org/10.11607/jop.1154.
50.
Headache Classification Subcommittee of the International Headache Society (IHS). (2013). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia: An International Journal of Headache, 33(9), 629–808. https://doi.org/10.1177/0333102413485658.
51.
Heir,G. M., Nasri-Heir,C., & Thomas,D. (2012). Complex regional pain syndrome following trigeminal nerve injury: Report of 2 cases. Oral Surg Oral Med Oral Path Oral Rad, 114, 733–739.
52.
Hoppenfeld,J. D. (2010). Cervical facet arthropathy and occipital neuralgia: Headache culprits. Curr Pain Headache Rep,, 14, 418–423.
53.
Hossain,M. Z., Ando,H., Unno,S., & Kitagawa,J. (2020). Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. International Journal of Molecular Sciences, 21(4), 1423. https://doi.org/10.3390/ijms21041423.
54.
Iannotti,F. A., Hill,C. L., Leo,A., Alhusaini,A., Soubrane,C., Mazzarella,E., Russo,E., Whalley,B. J., Di Marzo,V., & Stephens,G. J. (2014). Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chemical Neuroscience, 5(11), 1131–1141. https://doi.org/10.1021/cn5000524.
Jensen,T. S., Madsen,C. S., & Finnerup,N. B. (2009). Pharmacology and treatment of neuropathic pains. Current Opinion in Neurology, 22(5), 467–474. https://doi.org/10.1097/WCO.0b013e3283311e13.
57.
Kanbayashi,Y., & Hosokawa,T. (2013). Vaccination against and treatment of acute herpes zoster for prevention of post-herpetic neuralgia. Current Pain and Headache Reports, 17(10), 371. https://doi.org/10.1007/s11916-013-0371-6.
58.
Khavanin,N., Carl,H. M., Yang,R., & Dorafshar,A. H. (2019). Surgical “Safe Zone": Rapid Anatomical Identification of the Lesser Occipital Nerve. Journal of Reconstructive Microsurgery, 35(5), 341–345. https://doi.org/10.1055/s-0038-1676601.
59.
Kim,E., & Cucchiaro,G. (2019). Occipital Nerve Blocks for Relief of Headaches in Patients With Ventriculoperitoneal Shunts: A Case Series. Journal of Child Neurology, 34(11), 674–678. https://doi.org/10.1177/0883073819853079.
60.
Komarnitki,I., Andrzejczak-Sobocinska,A., Tomcyzk,J., Deszczynska,K., & Ciszek,B. (2012). Clinical anatomy of the auriculotemporal nerve in the area of the infratemporal fossa. Folia Morphologica, 71(3), 187–193.
61.
Kopsky,D. J., & Keppel Hesselink,J. M. (2017). Topical phenytoin for the treatment of neuropathic pain. Journal of Pain Research, 10, 469–473. https://doi.org/10.2147/JPR.S129749.
62.
Knezevic,N. N., Tverdohleb,T., Nikibin,F., Knezevic,I., & Candido,K. D. (2017). Management of chronic neuropathic pain with single and compounded topical analgesics. Pain Management, 7(6), 537–558. https://doi.org/10.2217/pmt-2017-0020.
63.
Kuhweide,R., Van de Steene,V., Vlaminck,S., etal.Ramsay Hunt syndrome: pathophysiology of cochleovestibular symptoms. J Laryngol Otol, 116(10) (2002), 844–848.
64.
Laprairie,R. B., Bagher,A. M., Kelly,M. E., & Denovan-Wright,E. M. (2015). Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. British Journal of Pharmacology, 172(20), 4790–4805. https://doi.org/10.1111/bph.13250.
65.
Lavin,P. J., & Workman,R. (2001). Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids. Headache, 41(9), 902–904.
66.
Lemos,L., Flores,S., Oliveira,P., & Almeida,A. (2008). Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. The Clinical Journal of Pain, 24(1), 64–75. https://doi.org/10.1097/AJP.0b013e318158011a.
67.
Linke,R., Wollenberg,B., & Schröder,U. (2012). Diagnostik und Management von Schmerzsyndromen nach Parotidektomie [Diagnosis and management of pain syndromes following parotidectomy]. HNO, 60(8), 725–729. https://doi.org/10.1007/s00106-011-2415-8.
68.
Mahoney,J. M., Vardaxis,V., Moore,J. L., Hall,A. M., Haffner,K. E., & Peterson,M. C. (2012). Topical ketamine cream in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled, double-blind initial study. Journal of the American Podiatric Medical Association, 102(3), 178–183. https://doi.org/10.7547/1020178.
69.
Martelletti,P., Barbanti,P., Grazzi,L., Pierangeli,G., Rainero,I., Geppetti,P., Ambrosini,A., Sarchielli,P., Tassorelli,C., Liebler,E., de Tommaso,M., PRESTO Study Group (2018). Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. The Journal of Headache and Pain, 19(1), 101. https://doi.org/10.1186/s10194-018-0929-0.
70.
Martin,W. J., & Forouzanfar,T. (2011). The efficacy of anticonvulsants on orofacial pain: a systematic review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 111(5), 627–633. https://doi.org/10.1016/j.tripleo.2011.01.033.
71.
Morra,M. E., Elgebaly,A., Elmaraezy,A., Khalil,A. M., Altibi,A. M., Vu,T. L., Mostafa,M. R., Huy,N. T., & Hirayama,K. (2016). Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials. The Journal of Headache and Pain, 17(1), 63. https://doi.org/10.1186/s10194-016-0651-8.
72.
Moulin,D., Boulanger,A., Clark,A. J., Clarke,H., Dao,T., Finley,G. A., Furlan,A., Gilron,I., Gordon,A., Morley-Forster,P. K., Sessle,B. J., Squire,P., Stinson,J., Taenzer,P., Velly,A., Ware,M. A., Weinberg,E. L., Williamson,O. D., Canadian Pain Society (2014). Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Research & Management, 19(6), 328–335. https://doi.org/10.1155/2014/754693.
73.
Mücke,M., Phillips,T., Radbruch,L., Petzke,F., & Häuser,W. (2018). Cannabis-based medicines for chronic neuropathic pain in adults. The Cochrane Database of Systematic Reviews, 3(3), CD012182. https://doi.org/10.1002/14651858.CD012182.pub2.
74.
National Institute for Health and Care Excellence (NICE). Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. 2013.
75.
Ness,T. J., Jones,L., & Smith,H. (2002). Use of compounded topical analgesics–results of an Internet survey. Regional Anesthesia and Pain Medicine, 27(3), 309–312. https://doi.org/10.1053/rapm.2002.31212.
76.
Nova,C. V., Zakrzewska,J. M., Baker,S. R., & Riordain,R. N. (2020). Treatment Outcomes in Trigeminal Neuralgia-A Systematic Review of Domains, Dimensions and Measures. World Neurosurgery: X, 6, 100070. https://doi.org/10.1016/j.wnsx.2020.100070.
77.
Nusair,Y. M., & Dickenson,A. J. (2003). Great auricular causalgia: an unusual complication of excision of the submandibular gland. The British Journal of Oral & Maxillofacial Surgery, 41(5), 334–335. https://doi.org/10.1016/s0266-4356(03)00116-5.
78.
Obermann,M. (2010). Treatment options in trigeminal neuralgia. Therapeutic Advances in Neurological Disorders, 3(2), 107–115. https://doi.org/10.1177/1756285609359317.
79.
Okeson,J. P. (2014). Bell’s Orofacial Pains, 7th Ed. Hanover Park, IL. Quintessence Publishing Co, Inc.
80.
Okuda,Y., Matsumoto,T., Shinohara,M., Kitajima,T., & Kim,P. (2001). Sudden unconsciousness during a lesser occipital nerve block in a patient with the occipital bone defect. European Journal of Anaesthesiology, 18(12), 829–832. https://doi.org/10.1046/j.1365-2346.2001.01018.x.
81.
Pareja,J. A., López-Ruiz,P., Mayo,D., Villar-Quiles,R. N., Cárcamo,A., Gutiérrez-Viedma,Á., Lastarria,C. P., Romeral,M., Yangüela,J., & Cuadrado,M. L. (2017). Supratrochlear Neuralgia: A Prospective Case Series of 15 Patients. Headache, 57(9), 1433–1442. https://doi.org/10.1111/head.13158.
82.
Park,S. W., Choi,J. Y., & Jung,K. J. (2018). Management of Great Auricular Neuralgia Confirmed by Electrophysiologic Examination: A Case Report. Journal of Oral & Facial Pain and Headache, 32(32), e53–e56. https://doi.org/10.11607/ofph.2144.
83.
Patra,D. P., Savardekar,A. R., Dossani,R. H., Narayan,V., Mohammed,N., & Nanda,A. (2018). Repeat Gamma Knife radiosurgery versus microvascular decompression following failure of GKRS in trigeminal neuralgia: a systematic review and meta-analysis. Journal of Neurosurgery, 1-10. Advance online publication. https://doi.org/10.3171/2018.5.JNS18583.
84.
Peppin,J. F., Majors,K., Webster,L. R., Simpson,D. M., Tobias,J. K., & Vanhove,G. F. (2011). Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain. Journal of Pain Research, 4, 385–392. https://doi.org/10.2147/JPR.S22954.
85.
Pertwee,R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199–215. https://doi.org/10.1038/sj.bjp.0707442.
86.
Pittelkow,T. P., Pagani-Estevez,G. L., Landry,B., Pingree,M. J., & Eldrige,J. S. (2016). Occipital Neuromodulation: A Surgical Technique with Reduced Complications. Pain Physician, 19(7), E1005–E1012.
87.
Przeklasa-Muszyńska,A., Skrzypiec,K., Kocot-Kępska,M., Dobrogowski,J., Wiatr,M., & Mika,J. (2017). Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly® device in prevention of primary headaches. Neurologiai Neurochirurgia Polska, 51(2), 127–134. https://doi.org/10.1016/j.pjnns.2017.01.004.
88.
Rhoton,A. L.Jr, , Kobayashi,S., & Hollinshead,W. H. (1968). Nervus intermedius. Journal of Neurosurgery, 29(6), 609–618. https://doi.org/10.3171/jns.1968.29.6.0609.
89.
Ross,A. K., & Bryskin,R. B. (2011). Regional Anesthesia In P.J. Davis, F.P. Cladis, E.K. Motoyoma (Eds.) Smith’s Anesthesia for Infants and Children. 8th ed. Philadelphia: Elsevier Mosby; 452-458.
90.
Russo,E. B., Burnett,A., Hall,B., & Parker,K. K. (2005). Agonistic properties of cannabidiol at 5-HTa receptors. Neurochemical Research, 30(8), 1037–1043. https://doi.org/10.1007/s11064-005-6978-1.
91.
Ryberg,E., Larsson,N., Sjögren,S., Hjorth,S., Hermansson,N. O., Leonova,J., Elebring,T., Nilsson,K., Drmota,T., & Greasley,P. J. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology, 152(7), 1092–1101. https://doi.org/10.1038/sj.bjp.0707460.
92.
Saarto,T., & Wiffen,P. J. (2007). Antidepressants for neuropathic pain. The Cochrane Database of Systematic Reviews, (4), CD005454. https://doi.org/10.1002/14651858.CD005454.pub2.
93.
Sahai-Srivastava,S., & Subhani,D. (2010). Adverse effect profile of lidocaine injections for occipital nerve block in occipital neuralgia. The Journal of Headache and Pain, 11(6), 519–523. https://doi.org/10.1007/s10194-010-0244-x.
94.
Sanchez-Larsen,A., Sopelana,D., Diaz-Maroto,I., Perona-Moratalla,A. B., Gracia-Gil,J., García-Muñozguren,S., Palazón-García,E., & Segura,T. (2018). Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia. European Journal of Pain (London, England), 22(6), 1080–1087. https://doi.org/10.1002/ejp.1192.
95.
Sambrook,P. J., & Goss,A. N. (2011). Severe adverse reactions to dental local anaesthetics: Prolonged mandibular and lingual nerve anaesthesia. Aust Dent J 2011; 56, 154–159.
96.
Shaefer,J. R., Khawaja,S. N., & Bavia,P. F. (2018). Sex, Gender, and Orofacial Pain. Dental Clinics of North America, 62(4), 665–682. https://doi.org/10.1016/j.cden.2018.06.001.
97.
Sharma,R., Phalak,M., Katiyar,V., Borkar,S., Kale,S. S., & Mahapatra,A. K. (2018). Microvascular decompression versus stereotactic radiosurgery as primary treatment modality for trigeminal neuralgia: A systematic review and meta-analysis of prospective comparative trials. Neurology India, 66(3), 688–694. https://doi.org/10.4103/0028-3886.232342.
98.
Sellers,A., & Simmons,M. (2019). Glossopharyngeal Neuralgia: A Multidimensional Challenge. South Dakota Medicine: the Journal of the South Dakota State Medical Association, 72(9), 393–395.
99.
Shackleton,T., Ram,S., Black,M., Ryder,J., Clark,G. T., & Enciso,R. (2016). The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 122(1), 61–71. https://doi.org/10.1016/j.oooo.2016.03.003.
100.
Sjaastad,O., Petersen,H. C., & Bakketeig,L. S. (2005). Supraorbital neuralgia. Vågå study of headache epidemiology. Cephalalgia: An International Journal of Headache, 25(4), 296–304. https://doi.org/10.1111/j.1468-2982.2004.00856.x.
101.
Smith,M. H., & Lung,K. E. (2006). Nerve injuries after dental injection: A review of the literature. J Can Dent Assoc2006; 72: 559–564.
102.
Speciali,J. G., & Gonçalves,D. A. (2005). Auriculotemporal neuralgia. Current Pain and Headache Reports, 9(4), 277–280. https://doi.org/10.1007/s11916-005-0037-0.
103.
Sprenger,T., & Seifert,C. L. (2013). Coma after greater occipital nerve blockade in a patient with previous posterior fossa surgery. Headache, 53(3), 548–550. https://doi.org/10.1111/head.12015.
104.
Standring,S., Borley,N. R., Collins,P., Crossman,A. R., Gatzoulis,M. A., Healy,J. C., Johnson,D., Mahadevan,V., Newell,R. L. M., & Wigley,C. B. (2008). Gray’s anatomy. The anatomical basis of clinical practice. Edinburgh: Elsevier.
105.
Stogicza,A., Trescot,A., & Rabago,D. (2019). New Technique for Cryoneuroablation of the Proximal Greater Occipital Nerve. Pain Practice: the Official Journal of World Institute of Pain, 19(6), 594–601. https://doi.org/10.1111/papr.12779.
106.
Straiker,A., Mitjavila,J., Yin,D., Gibson,A., & Mackie,K. (2015). Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model. Pharmacological Research, 99, 370–376. https://doi.org/10.1016/j.phrs.2015.07.017.
107.
Swedish Council on Health Technology Assessment. (2006). Methods of Treating Chronic Pain: A Systematic Review. Swedish Council on Health Technology Assessment (SBU).
108.
Sweet,J. A., Mitchell,L. S., Narouze,S., Sharan,A. D., Falowski,S. M., Schwalb,J. M., Machado,A., Rosenow,J. M., Petersen,E. A., Hayek,S. M., Arle,J. E., & Pilitsis,J. G. (2015). Occipital Nerve Stimulation for the Treatment of Patients With Medically Refractory Occipital Neuralgia: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline. Neurosurgery, 77(3), 332–341. https://doi.org/10.1227/NEU.0000000000000872.
109.
Sykes,J. M. (2009). Complications of Facial Implants in Complications In D.W. Eisele and R.V. Smith (Eds.) Head and Neck Surgery 2nd ed. Philadelphia: Mosby Elsevier; pp. 671-676.
110.
Tang,I. P., Freeman,S. R., Kontorinis,G., Tang,M. Y., Rutherford,S. A., King,A. T., & Lloyd,S. K. (2014). Geniculate neuralgia: a systematic review. The Journal of Laryngology and Otology, 128(5), 394–399.
111.
Taylor,J. C., Brauer,S., & Espir,M. L. (1981). Long-term treatment of trigeminal neuralgia with carbamazepine. Postgraduate Medical Journal, 57(663), 16–18. https://doi.org/10.1136/pgmj.57.663.16.
112.
Tentolouris-Piperas,V., Lee,G., Reading,J., O’Keeffe,A. G., Zakrzewska,J. M., & Cregg,R. (2018). Adverse effects of anti-epileptics in trigeminal neuralgiform pain. Acta Neurologica Scandinavica, 137(6), 566–574. https://doi.org/10.1111/ane.12901.
113.
Texakalidis,P., Xenos,D., Tora,M. S., Wetzel,J. S., & Boulis,N. M. (2019). Comparative safety and efficacy of percutaneous approaches for the treatment of trigeminal neuralgia: A systematic review and meta-analysis. Clinical Neurology and Neurosurgery, 182, 112–122. https://doi.org/10.1016/j.clineuro.2019.05.011.
114.
Tobin,J., & Flitman,S. (2011). Treatment of migraine with occipital nerve blocks using only corticosteroids. Headache, 51(1), 155–159. https://doi.org/10.1111/j.1526-4610.2010.01801.x.
115.
Tubbs,R. S., Salter,E. G., Wellons,J. C., Blount,J. P., & Oakes,W. J. (2007). Landmarks for the identification of the cutaneous nerves of the occiput and nuchal regions. Clinical Anatomy (New York, N.Y.), 20(3), 235–238. https://doi.org/10.1002/ca.20297.
116.
Van Buyten,J. P., Smet,I., Devos,M., & Vanquathem,N. E. (2019). High-Frequency Supraorbital Nerve Stimulation with a Novel Wireless Minimally Invasive Device for Post-Traumatic Neuralgia: A Case Report. Pain Practice: The Official Journal of World Institute of Pain, 19(4), 435–439. https://doi.org/10.1111/papr.12747.
117.
Waldman,S. D. (2015). Atlas of Interventional Pain Management (4th ed.). Philadelphia, PA: Saunders/Elsevier.
118.
Weiner,R. L., Garcia,C. M., & Vanquathem,N. (2017). A novel miniature, wireless neurostimulator in the management of chronic craniofacial pain: Preliminary results from a prospective pilot study. Scandinavian Journal of Pain, 17, 350–354. https://doi.org/10.1016/j.sjpain.2017.09.010.
119.
Wrzosek,A., Woron,J., Dobrogowski,J., Jakowicka-Wordliczek,J., & Wordliczek,J. (2015). Topical clonidine for neuropathic pain. The Cochrane Database of Systematic Reviews, 8(9), CD010967. https://doi.org/10.1002/14651858.CD010967.pub2.
120.
Wu,H., Zhou,J., Chen,J., Gu,Y., Shi,L., & Ni,H. (2019). Therapeutic efficacy and safety of radiofrequency ablation for the treatment of trigeminal neuralgia: a systematic review and meta-analysis. Journal of Pain Research, 12, 423–441. https://doi.org/10.2147/JPR.S176960.
121.
Xia,L., Zhong,J., Zhu,J., Wang,Y. N., Dou,N. N., Liu,M. X., Visocchi,M., & Li,S. T. (2014). Effectiveness and safety of microvascular decompression surgery for treatment of trigeminal neuralgia: a systematic review. The Journal of Craniofacial Surgery, 25(4), 1413–1417. https://doi.org/10.1097/SCS.0000000000000984.
122.
Yang,M., Zhou,M., He,L., Chen,N., & Zakrzewska,J. M. (2011). Non-antiepileptic drugs for trigeminal neuralgia. The Cochrane Database of Systematic Reviews, (1), CD004029. https://doi.org/10.1002/14651858.CD004029.pub3.
Zakrzewska,J. M., Chaudhry,Z., Nurmikko,T. J., Patton,D. W., & Mullens,E. L. (1997). Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain, 73(2), 223–230. https://doi.org/10.1016/s0304-3959(97)00104-8.
125.
Zakrzewska,J. M., & Linskey,M. E. (2014). Trigeminal neuralgia. BMJ (Clinical research ed.), 348, g474.
126.
Zakrzewska,J. M., & Patsalos,P. N. (1989). Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. Journal of Neurology Neurosurgery and Psychiatry, 52(4), 472–476. https://doi.org/10.1136/jnnp.52.4.472.
127.
Zakrzewska,J. M., Wu,J., & Brathwaite,T. S. (2018). A Systematic Review of the Management of Trigeminal Neuralgia in Patients with Multiple Sclerosis. World Neurosurgery, 111, 291–306. https://doi.org/10.1016/j.wneu.2017.12.147.
128.
Zakrzewska,J. M., Wu,J., Mon-Williams,M., Phillips,N., & Pavitt,S. H. (2017). Evaluating the impact of trigeminal neuralgia. Pain, 158(6), 1166–1174. doi: 10.1097/j.pain.0000000000000853
129.
Zhang,J., Yang,M., Zhou,M., He,L., Chen,N., & Zakrzewska,J. M. (2013). Non-antiepileptic drugs for trigeminal neuralgia. The Cochrane Database of Systematic Reviews, (12), CD00 4029. https://doi.org/10.1002/14651858.CD004029.pub4.
